Collegium Pharmaceutical, Inc.
Status: Publicly traded
Direct answer
Collegium Pharmaceutical, Inc. is publicly traded on NASDAQ under the ticker COLL.
Collegium Pharmaceutical, Inc. (COLL) is a specialized pharmaceutical firm dedicated to the development and marketing of medications for pain management. Its diverse product lineup features significant therapies aimed at addressing various pain conditions. A prominent offering is Xtampza ER, an extended-release, oral formulation of oxycodone, specifically engineered with properties to deter abuse. This particular...
Can you invest in Collegium Pharmaceutical, Inc.?
Yes. Collegium Pharmaceutical, Inc. trades publicly on NASDAQ as COLL.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Collegium Pharmaceutical, Inc.
Detailed equity research is provided by MarketSnap.